Supplemental Figures S1, S2, and S3 from Circulating Tumor DNA as an Early Indicator of Response to T-cell Transfer Immunotherapy in Metastatic Melanoma

Fig. S1. castPCR{trade mark, serif} design, analytical sensitivity and specificity, and cfDNA measurements Fig. S2. Mutational analysis of tumor specimens from 93 NCI TIL patients Fig. S3. Cases excluded from pattern analysis